Found 7 matching trials
A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ
PHASE1This is an open-label and triple cohort study of the safety and efficacy of...
Location
The First Affiliated Hospital of Sun Yat-sen University
Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions
PHASE1This is an single arm clinical study of the safety and efficacy of T512 to ...
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1Phase I, open-label, dose-escalation and dose-expansion study evaluating th...
Status
Active Not Recruiting
Location
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
PHASE1First-in-human, open-label, dose-finding and dose-expansion study of UCART2...
Location
The University of Chicago Medical Center (UCMC)
Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
PHASE1This is a Phase I, FIH, open-label, dose escalation study evaluating Safety...
Location
UCSF Medical Center- Helen Diller Family Comprehensive Cancer Center
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
PHASE1This is a first-in-human, open-label, dose escalation and expansion study o...
Location
University of California, Los Angeles (UCLA) - Medical Center
Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia
PHASE1This is a Phase I, open-label, dose escalation study of UCART123 administer...
Location
Multiple Locations